BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29553339)

  • 21. Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.
    Labarca JA; Salles MJ; Seas C; Guzmán-Blanco M
    Crit Rev Microbiol; 2016; 42(2):276-92. PubMed ID: 25159043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the Impact of Antibiotic Exposures as Time-Dependent Variables on the Acquisition of Carbapenem-Resistant Acinetobacter baumannii.
    Munoz-Price LS; Rosa R; Castro JG; Laowansiri P; Latibeaudiere R; Namias N; Tarima S
    Crit Care Med; 2016 Oct; 44(10):e949-56. PubMed ID: 27167999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
    Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
    Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia.
    Aly MM; Abu Alsoud NM; Elrobh MS; Al Johani SM; Balkhy HH
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1759-1766. PubMed ID: 27527351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
    Stoeva T; Higgins PG; Bojkova K; Seifert H
    Clin Microbiol Infect; 2008 Jul; 14(7):723-7. PubMed ID: 18558947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems.
    Yoon EJ; Kim JO; Yang JW; Kim HS; Lee KJ; Jeong SH; Lee H; Lee K
    J Antimicrob Chemother; 2017 Oct; 72(10):2708-2714. PubMed ID: 29091183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
    Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
    J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental exposure to carbapenem-resistant Acinetobacter baumannii as a risk factor for patient acquisition of A. baumannii.
    Rosa R; Arheart KL; Depascale D; Cleary T; Kett DH; Namias N; Pizano L; Fajardo-Aquino Y; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):430-3. PubMed ID: 24602951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil.
    Dias VC; Diniz CG; Peter AC; Bastos AN; Bastos VQ; Bastos LQ; Da Silva VL
    J Infect Dev Ctries; 2016 Jun; 10(6):544-53. PubMed ID: 27367001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
    Kumar A; Randhawa VS; Nirupam N; Rai Y; Saili A
    J Infect Dev Ctries; 2014 Aug; 8(8):1049-54. PubMed ID: 25116673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
    Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii.
    Moon C; Kwak YG; Kim BN; Kim ES; Lee CS
    J Infect Chemother; 2013 Oct; 19(5):916-9. PubMed ID: 23619757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.